These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7140895)

  • 1. Aluminum neurotoxicity in the absence of neurofibrillary degeneration in CA1 hippocampal pyramidal neurons in vitro.
    Farnell BJ; De Boni U; Crapper McLachlan DR
    Exp Neurol; 1982 Nov; 78(2):241-58. PubMed ID: 7140895
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in excitability of CA1 pyramidal neurons in slices prepared from AlCl3-treated rabbits.
    Franceschetti S; Bugiani O; Panzica F; Tagliavini F; Avanzini G
    Epilepsy Res; 1990; 6(1):39-48. PubMed ID: 2357954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental neurofibrillary degeneration and altered electrical activity.
    Crapper DR
    Electroencephalogr Clin Neurophysiol; 1973 Dec; 35(6):575-88. PubMed ID: 4128153
    [No Abstract]   [Full Text] [Related]  

  • 4. Synaptic and nonsynaptic determinants of excitability changes in aluminum-intoxicated rabbit CA1 pyramidal neurons studied in vitro.
    Franceschetti S; Bugiani O; Panzica F; Avanzini G
    Epilepsy Res Suppl; 1992; 8():313-20. PubMed ID: 1358102
    [No Abstract]   [Full Text] [Related]  

  • 5. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus.
    Dutar P; Lamour Y; Nicoll RA
    Eur J Pharmacol; 1989 May; 164(2):355-60. PubMed ID: 2474449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary degeneration induced by systemic aluminum.
    Boni UD; Otvos A; Scott JW; Crapper DR
    Acta Neuropathol; 1976 Aug; 35(4):285-94. PubMed ID: 961381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity.
    Scholtz CL; Swash M; Gray A; Kogeorgos J; Marsh F
    Clin Neuropathol; 1987; 6(3):93-7. PubMed ID: 3608291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phosphodiesterase inhibition on the excitability of hippocampal pyramidal neurons in vitro.
    Gaal L; Schudt C; Illes P
    Eur J Pharmacol; 1991 Sep; 202(1):117-20. PubMed ID: 1723951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention.
    Crapper DR; Dalton AJ
    Physiol Behav; 1973 May; 10(5):935-45. PubMed ID: 4736728
    [No Abstract]   [Full Text] [Related]  

  • 10. Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem.
    Kowall NW; Pendlebury WW; Kessler JB; Perl DP; Beal MF
    Neuroscience; 1989; 29(2):329-37. PubMed ID: 2725861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal potential for glutamate responses in hippocampal pyramidal cells.
    Langomoen IA; Hablitz JJ
    Neurosci Lett; 1981 Apr; 23(1):61-5. PubMed ID: 6112722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A paradox after systemic kainate injection in rats: lesser damage of hippocampal CA1 neurons after higher doses.
    Balchen T; Berg M; Diemer NH
    Neurosci Lett; 1993 Dec; 163(2):151-4. PubMed ID: 8309622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor enhances short-term potentiation and facilitates induction of long-term potentiation in rat hippocampal slices.
    Abe K; Xie FJ; Saito H
    Brain Res; 1991 Apr; 547(1):171-4. PubMed ID: 1860069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration.
    Crapper DR; Tomko GJ
    Brain Res; 1975 Oct; 97(2):253-64. PubMed ID: 1236766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin(14) and -(28) but not somatostatin(1-12) hyperpolarize CA1 pyramidal neurons in vitro.
    Watson TW; Pittman QJ
    Brain Res; 1988 May; 448(1):40-5. PubMed ID: 2898967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressing encephalomyelopathy with muscular atrophy, induced by aluminum powder.
    Bugiani O; Ghetti B
    Neurobiol Aging; 1982; 3(3):209-22. PubMed ID: 7162550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative topography of aluminum in the rabbit with fibrillar degeneration of neurons in experimental encephalopathy].
    Smialek M
    Neuropatol Pol; 1967; 5(2):159-90. PubMed ID: 6046257
    [No Abstract]   [Full Text] [Related]  

  • 18. Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner.
    Moyer JR; Thompson LT; Black JP; Disterhoft JF
    J Neurophysiol; 1992 Dec; 68(6):2100-9. PubMed ID: 1491260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of caffeine on hippocampal pyramidal cells in vitro.
    Greene RW; Haas HL; Hermann A
    Br J Pharmacol; 1985 May; 85(1):163-9. PubMed ID: 4027463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine increases excitability of CA1 hippocampal pyramidal cells.
    Beck SG
    Synapse; 1992 Apr; 10(4):334-40. PubMed ID: 1585262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.